Estudio comparativo entre cirugía primaria y cirugía de intervalo en el estadio iiic del cáncer de ovario
Explore this paper's citation graph
Summary
La cirugia primaria optima completa presenta una tasa de supervivencia (SPV) y un PLE (periodo libre de enfermedad) mayor que las pacientes a quienes se les realiza quimioterapia neoadyuvante y cirugio de intervalo optima completeta, en el tratamiento del cancer epitelial de ovario.
- Type
- article
- Published
- 2014-12-15
- Cited by
- 0
- References
- 408
- OpenAlex
- https://openalex.org/W1548036032
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:161478246
Keywords
Medicine, Gynecology
References
- Is there a "best" choice of second-line agent in the treatment of recurrent, potentially platinum-sensitive ovarian cancer?
- The significance of serum CA 125 elevation in malignant and nonmalignant diseases.
- Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications.
- Palliative surgery for recurrent bowel obstruction due to advanced ovarian cancer.
- Are nodal metastases in ovarian cancer chemoresistant lesions? Analysis of nodal involvement in 105 patients treated with preoperative chemotherapy.
- Diagnostic value of CA125 as a predictor of recurrence in advanced ovarian cancer.
- Clinical and Histologic Studies of Ovarian Carcinoma: Long - Term Follow - Up of 990 Cases
- Relationship between endometriosis and ovarian cancer.
- Prevention and early detection of ovarian cancer: mission impossible?
- Serum CA-125 measurements > 65 U/mL. Clinical value.
- The biology of ovarian cancer.
- Neoadjuvant intraarterial chemotherapy and embolization in treatment of advanced ovarian epithelial carcinoma.
- A pilot study of weekly docetaxel therapy for recurrent ovarian cancer, tubal cancer, and primary peritoneal cancer.
- Neoadjuvant chemotherapy for ovarian cancer.
- Clinical assessment of neoadjuvant chemotherapy and interval cytoreductive surgery for unresectable advanced ovarian cancer.
- Paclitaxel (Taxol)/carboplatin combination chemotherapy in the treatment of advanced ovarian cancer.
- Preoperative serum vascular endothelial growth factor levels: significance in ovarian cancer.
- Surgical staging and cytoreductive surgery of epithelial ovarian cancer
- International Collaborative Ovarian Neoplasm Trial 1 and Adjuvant ChemoTherapy In Ovarian Neoplasm Trial: Two Parallel Randomized Phase III Trials of Adjuvant Chemotherapy in Patients With Early-Stage Ovarian Carcinoma.
- A prospective study of obesity and cancer risk (Sweden)
Cited by
No citing papers recorded for this paper.
Related papers
No related papers recorded.